The nation of Zimbabwe has rejected a significant US health deal valued at 367 million US dollars (272 million pounds) spanning five years over Washington's insistence on sensitive information.
The decision came to light following a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesperson later explained that the United States was requesting health data for scientific study and commercial gain but was not willing to guarantee the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate process of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged further dialogue to secure a agreement acceptable to all parties so the country's critical HIV programme can proceed.
Wider Context
This development comes after a comparable case in neighbouring Kenya, where a high court blocked a related deal with the US following concerns were raised about the safety of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and responsibility.
As per statements, Sixteen African countries have so far agreed to these new agreements, constituting over $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership would have delivered significant advantages for the people of Zimbabwe, particularly the 1.2 million currently on HIV treatment through American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to share its biological resources and data over an extended period, without any corresponding guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Put simply, our country would supply the raw materials for scientific discovery with no assurance that the end products would be available to our citizens if a future pandemic arise."
Sovereignty and Global Health
He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting systems previously set up via the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.
"This mechanism is designed to guarantee that when a country provides its data, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to create them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome further dialogue with our American counterparts on how subsequent co-operation could be designed in a way that honours the independence and interests of both nations."
Health Experts Response
Medical experts stated it understood the government's concerns, but urged that negotiations should continue considering a large portion of the country's HIV programmes were funded by external financing.
"In cases where specific concerns exist, including those relating to information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it added.
This impasse emphasises the ongoing debate between receiving vital foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.